Press release
Deadline on August 17th coming up in Lawsuit for Investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI)
A Deadline is coming up on August 17, 2020 in the lawsuit for certain investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI).
Investors who purchased shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI) have certain options and there are strict and short deadlines running. Deadline: August 17, 2020. NASDAQ: CEMI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of Chembio Diagnostics, Inc. (NASDAQ: CEMI) common shares between April 1, 2020 and June 16, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between April 1, 2020 and June 16, 2020 the Company failed to disclose that, the Company’s Dual Path Platform (“DPP”) COVID-19 test did not provide high-quality results and there were material performance concerns with the accuracy of the test such that it was not reasonable to believe that the test may be effective in detecting antibodies against SARS-CoV-2; and as a result, there was a material risk to public health from the false test results.
Those who purchased shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI) have certain options and should contact the Shareholders Foundation.
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on August 17th coming up in Lawsuit for Investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI) here
News-ID: 2098357 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Chembio
Zika Virus Testing Market 2025 Driving Factors Forecast Research 2031 | Chembio, …
QYResearch A newly published report titled "Global Zika Virus Testing Market Insights, Forecast to 2031" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The Zika Virus Testing report also highlights the key driving factors and restraints that are impacting the growth. For a comprehensive understanding, the professionals have reviewed the regulatory scenario, market entry…
Human Immunodeficiency Virus Rapid Test Kits Market Is Booming So Rapidly | Abbo …
The Global Human Immunodeficiency Virus Rapid Test Kits Market Size is estimated at $10.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 7.9% to reach $20.6 Billion by 2034.
The latest study released on the Global Human Immunodeficiency Virus Rapid Test Kits Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Human Immunodeficiency Virus Rapid Test Kits market study covers…
HIV Self-test Kits Market Analysis, Research Study 2027 || OraSure Technologies, …
The global HIV Self-test Kits market is poised for substantial growth, projected to reach a valuation of US$ 471 Mn by the end of 2027, according to a comprehensive study conducted by Transparency Market Research (TMR). The market is anticipated to expand at a healthy CAGR of 5.4% during the forecast period from 2019 to 2027.
𝐓𝐨 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐟𝐮𝐫𝐭𝐡𝐞𝐫, 𝐠𝐞𝐭 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝…
Global Covid Testing Kit Market Growth Drivers, Competitive Landscape 2021-2027 …
Global Covid Testing Kit Market Size 2021-2027
Worldwide Covid Testing Kit market 2021 Research Report presents a professional and complete analysis of Global Covid Testing Kit Market on the current situation. Covid Testing Kit Market report includes development plans and policies along with Covid Testing Kit manufacturing processes and price structures. Global Covid Testing Kit Market 2021 research report offers the analytical view of the industry by studying different factors like…
POC Diagnostics Market to See Huge Growth by 2026 | Alere, Danaher, Chembio Diag …
HTF MI released new intelligence report on "Global POC Diagnostics Market" aiming to deliver competitive advantage. The study discusses how various medical equipment manufacturers are reinventing their POC Diagnostics business and operating models with future outlook. Some of the Manufacturers considered in the study are Nipro Diagnostics, Helena Laboratories, Quidel, BioMerieux, Alere, Danaher, Chembio Diagnostics, Johnson & Johnson, Trinity Biotech, OraSure Technologies, Abbott Laboratories, Nova Biomedical, Beckman Coulter, Siemens Healthcare,…
Lawsuit filed for Investors in shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI …
The Shareholders Foundation announced that an investor, who purchased shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI), filed a lawsuit over alleged violations of Federal Securities Laws by Chembio Diagnostics, Inc.
Investors who purchased shares of Chembio Diagnostics, Inc. (NASDAQ: CEMI) have certain options and for certain investors are short and strict deadlines running. Deadline: August 17, 2020. NASDAQ: CEMI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
